← Home India · nd-india

Cognition Therapeutics receives US patent covering a novel crystalline form, or polymorph, of zervimesine (CT1812)

Source: pharmabiz · 2026-10-14T04:00:00 UTC

Cognition Therapeutics, Inc., a clinical─stage company developing drugs that treat neurodegenerative disorders, announced that the United States Patent and Trademark Office (USPTO) has granted the company a patent

Full article text belongs to the original publisher. Moogle News shows the headline/summary and sends you to the source.

Read full story on publisher site →

Related in India

What happens after Delhi Police detains you? I saw it first hand - Newslaundry

google

Vedanta says its girl-focused programmes reached over 10 lakh girls in FY26

edexlive

Providence Chiropractor Dr. Mark Mulak Renews Certified Professional in Patient Safety (CPPS) Credential

einpresswire

NHL expands commercial portfolio with Expedia travel partnership

sportsmintmedia

Blancco Transforms IT Asset Lifecycle Management and Data Erasure with Industry-First Agentic Platform

einpresswire

Trinetra Guard Schedules EM6000Auto Demonstrations at ATA MCE Booth 20008

einpresswire